CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease. by Wendt, E, Keshav, S

The role of CCL25 and CCR9 in intestinal inflammation by Wendt, E, Emily Rose Wendt

Ratiometric analysis of fura red by flow cytometry: a technique for monitoring intracellular calcium flux in primary cell subsets. by Wendt, E, Ferry, H, Greaves, D, Keshav, S

Correlation between the Ulcerative Colitis Endoscopic Index of severity (UCEIS) and intestinal mucosal calprotectin (IMC) in acute severe ulcerative colitis. by Chamoun, J, Wang, L, Corte, C, Clifton, L, Wendt, E, Guirgis, M, Travis, S, Keshav, S

Beyond histological remission: the role of mucosal calprotectin as a potential predictor of outcomes in ulcerative colitis. by Guirgis, M, Wendt, E, Wang, L, Walsh, A, Burger, D, Bryant, R, Kent, A, Adamson, R, Brain, O, Travis, S, Keshav, S

Circulating and Tissue-Resident CD4+ T Cells With Reactivity to Intestinal Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammation by Hegazy, AN, West, NR, Stubbington, MJT, Wendt, E, Suijker, KIM, Datsi, A, This, S, Danne, C, Campion, S, Duncan, SH, Owens, BMJ, Uhlig, HH, McMichael, A, Bergthaler, A, Teichmann, SA, Keshav, S, Powrie, F

Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease. by Walters, M, Wang, Y, Lai, N, Baumgart, T, Zhao, B, Dairaghi, D, Bekker, P, Ertl, L, Penfold, M, Jaen, J, Keshav, S, Wendt, E, Pennell, A, Ungashe, S, Wei, Z, Wright, J, Schall, T